<!doctype html>
<html class="no-js" lang="">
<head>
  <meta charset="utf-8">
  <meta name="description" content="">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>OncoKB Card</title>

  <link rel="apple-touch-icon" href="apple-touch-icon.png">
  <!-- Place favicon.ico in the root directory -->

  <!-- build:css styles/vendor.css -->
  <!-- bower:css -->
  <link rel="stylesheet" href="/bower_components/qtip2/jquery.qtip.min.css" />
  <!-- endbower -->
  <!-- endbuild -->

  <!-- build:css styles/main.css -->
  <link rel="stylesheet" href="styles/main.css">
  <!-- endbuild -->
  <!-- build:js scripts/vendor/modernizr.js -->
  <script src="/bower_components/modernizr/modernizr.js"></script>
  <!-- endbuild -->
</head>
<body>
<!--[if lt IE 10]>
<p class="browserupgrade">You are using an <strong>outdated</strong> browser. Please <a href="http://browsehappy.com/">upgrade
  your browser</a> to improve your experience.</p>
<![endif]-->
<div class="container" id="main">
</div>

<!-- build:js scripts/vendor.js -->
<!-- bower:js -->
<script src="/bower_components/jquery/dist/jquery.js"></script>
<script src="/bower_components/underscore/underscore.js"></script>
<script src="/bower_components/ev-emitter/ev-emitter.js"></script>
<script src="/bower_components/imagesloaded/imagesloaded.js"></script>
<script src="/bower_components/qtip2/jquery.qtip.js"></script>
<script src="/bower_components/qtip2/basic/jquery.qtip.js"></script>
<!-- endbower -->
<!-- endbuild -->

<script src="/bower_components/bootstrap-sass/assets/javascripts/bootstrap.js"></script>

<!-- build:js scripts/main.js -->
<script src="scripts/main.js"></script>
<!-- endbuild -->

<script>
  $(document).ready(function() {
    $('#main').load('template.html', function() {
      _.templateSettings = {
        evaluate: /<@([\s\S]+?)@>/g,
        interpolate: /\{\{(.+?)\}\}/g
      };

      var meta = {
        title: 'BRAF V600E in Melanoma',
        gene: 'BRAF',
        oncogenicity: 'Oncogenic',
//        oncogenicity: '',
        oncogenicityPmids: '',
        mutationEffect: 'Gain-of-function',
//        mutationEffect: '',
//        mutationEffectPmids: '',
        mutationEffectPmids: '12068308, 15035987, 16273091, 20179705, 23153539, 25265492, 25287827, 25399551',
        clinicalSummary: 'BRAF, an intracellular kinase, is frequently mutated in melanoma, thyroid and lung cancers. The BRAF V600E mutation is known to be oncogenic. The RAF-inhibitors dabrafenib and vemurafenib, alone and in combination with the MEK-inhibitors trametinib and cobimetinib respectively, are FDA-approved for the treatment of patients with BRAF V600E and V600K mutant melanoma. Data support using the combination therapies dabrafenib plus trametinib or vemurafenib plus cobimetinib instead of single agent dabrafenib, vemurafenib, or trametinib.',
        biologicalSummary: 'The PIK3CA E542K mutation abrogates the inhibitory effect of the p85 subunit, and results in constitutive activation of PIK3CA enzymatic activity (<i class="fa fa-book" qtip-content="20593314" style="color:black" data-hasqtip="1202"></i>). This aberrant activation of PIK3CA promotes downstream activation of AKT and other PIP3 dependent effectors, eventually leading to increased cell survival, proliferation, and motility. In vitro experiments in chicken embryo fibroblasts (CEFs), Ba/F3 cells, and MCF10A cells have demonstrated that this PIK3CA mutation promotes growth factor-independent proliferation; results in increased anchorage independent colony formation; and augments tumor growth in vivo (<i class="fa fa-book" qtip-content="17376864,26627007,16432179" style="color:black" data-hasqtip="1203"></i>).',
//        biologicalSummary: '',
//        biologicalSummary: undefined,
        treatments: [
          {
            level: '1',
            variant: 'V600E',
            treatment: 'Dabrafenib',
            cancerType: 'Melanoma',
            pmids: '22608338, 22735384, 23051966, 23918947, 25089220, 25265492, 25399551',
            abstracts: [{
              abstract: 'content',
              link: 'http://oncokb.org'
            }, {
              abstract: 'content',
              link: ''
            }],
            description:'22608338, 22735384, 23051966, 23918947, 25089220, 25265492, 25399551'
          },
          {
            level: '1',
            variant: 'V600E',
            treatment: 'Trametinib',
            cancerType: 'Melanoma',
            pmids: '20818844, 24508103, 25399551'
          },
          {
            level: '1',
            variant: 'V600E/K',
            treatment: 'Trametinib',
            cancerType: 'Melanoma',
            pmids: '22663011, 23846731, 25265492, 25399551'
          },
          {
            level: '1',
            variant: 'V600E/K',
            treatment: 'Trametinib + Dabrafenib',
            cancerType: 'Melanoma',
            pmids: '22663011, 23020132, 23846731, 25089220, 25265492, 25287827, 25399551'
          },
          {
            level: '1',
            variant: 'V600E/K',
            treatment: 'Vemurafenib + Cobimetinib',
            cancerType: 'Melanoma',
            pmids: '25265494'
          },
//          {
//            level: '2A',
//            variant: 'V600E/K',
//            treatment: 'Trametinib + Dabrafenib',
//            cancerType: 'Melanoma/Non-Small Cell Lung Cancer',
//            pmids: '22663011,23846731,25265492,25399551'
//          }
          // {
          //   level: '3A',
          //   variant: 'V600E',
          //   treatment: 'Vemurafenib',
          //   cancerType: 'Melanoma',
          //   pmids: '22663011,23846731,25265492,25399551'
          // },
          // {
          //   level: '3B',
          //   variant: 'V600E/K',
          //   treatment: 'Vemurafenib+Cobimetinib',
          //   cancerType: 'Melanoma',
          //   pmids: ''
          // },
          // {
          //   level: '4',
          //   variant: 'V600E',
          //   treatment: 'Cobimetinib',
          //   cancerType: 'Melanoma',
          //   pmids: ''
          // },
          // {
          //   level: 'R1',
          //   variant: 'V600E',
          //   treatment: 'Cobimetinib',
          //   cancerType: 'Melanoma',
          //   pmids: '22663011,23846731,25265492,25399551'
          // },
        ]
      };
      OncoKBCard.init(meta, "#main");
    });
  })
</script>
</body>
</html>
